ICICI Bank Limited is one of India's largest private sector lenders and a diversified financial services group. Operating through an extensive network of branches, ATMs, and digital channels, the bank serves retail, corporate, business banking, and rural customers while also offering life and general insurance, asset management, and treasury services through its subsidiaries.
ICICI Bank is widely regarded as a leader in digital banking in India and maintains a strong retail deposit franchise, healthy capital ratios, and disciplined underwriting standards. Its American Depositary Receipts (ADRs) trade on the New York Stock Exchange under the ticker IBN, giving international investors direct exposure to one of India's most prominent financial institutions and a key benchmark name within the country's banking sector.
Over the last 30 days, IBN has risen approximately 17.6%, moving from a closing price of $29.48 on October 19 to about $34.67. The rally accelerated sharply in early November, with the ADR reaching a 52-week high near $34.98 during the period before easing slightly. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The quarterly picture tells a similar but more uneven story. Over the trailing three months, IBN has gained roughly 17% from levels near $29.60 in mid-August. That advance was not a straight line: shares pulled back into the high-$27 range in late September before a sustained recovery took hold in October and accelerated through November, meaning most of the quarterly gain was concentrated in recent weeks.
Several verified factors contributed to the stock's sharp rise. On October 17, ICICI Bank reported second-quarter FY2027 results showing a 20.1% year-over-year increase in standalone net profit to ₹14,843 crore, with net interest income up 17.7% to ₹25,339 crore. Loan growth of 30% and deposit growth of 27.1% underscored strong business momentum, while the gross non-performing asset ratio improved to 1.20% from 1.58% a year earlier.
The earnings were followed by a broad re-rating of Indian banking stocks in November. The Nifty Bank index surged to record highs as improving credit growth, stable asset quality, and expectations of easing funding pressures drew foreign and domestic inflows into the sector, with IBN among the biggest beneficiaries.
Analyst activity added further support. In late October, ICICI Bank was upgraded to a Zacks Rank #1 (Strong Buy), and consensus price targets implied meaningful upside from prevailing levels. The combination of strong fundamentals, favorable sector rotation, and constructive analyst coverage helped drive IBN to multi-year highs within the 30-day window.
Over the last quarter, IBN's performance reflected a transition from consolidation to a decisive breakout. Shares traded in a relatively narrow band through August before softening into late September, when broader market volatility and near-term concerns weighed on Indian financials.
The narrative shifted in October and November. Strong quarterly earnings, improving asset quality, and a sector-wide rally powered by renewed foreign portfolio inflows and easing funding-cost expectations drove a sustained advance. The bank's healthy capital position—with capital adequacy reported at 16.68%—and its diversified revenue base reinforced investor conviction that the positive momentum could be maintained. By November, IBN was trading at or near record levels, reflecting a clear shift in sentiment from earlier in the quarter.
Several factors are likely to shape IBN's trajectory in the near term. The sustainability of net interest margin, which slipped to 4.18% partly due to the cost of FCNR(B) deposit inflows, remains a key focus, as does the pace of credit growth excluding the one-time boost from the central bank's swap window.
Investors should also monitor upcoming quarterly results, the trajectory of asset quality metrics, the Reserve Bank of India's monetary policy stance, and the direction of foreign portfolio flows into Indian equities. Sector-wide valuation levels following the sharp November rally may introduce additional volatility. These are important considerations for evaluating the stock, though they do not constitute investment advice or a basis for predicting future performance.
In my analysis of names like IBN, I often turn to Tickeron’s AI Daily Buy/Sell Signals to cross-check momentum and compare setups across the banking sector. It provides a quick, data-driven layer that complements fundamental review without replacing it. From what I see, these tools help highlight patterns that might otherwise get overlooked in fast-moving rallies.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for IBN crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 55%.
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on IBN as a result. In 42 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 49%.
IBN moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where IBN advanced for three days, in 145 of 287 cases, the price rose further within the following month. The odds of a continued upward trend are 51%.
The Aroon Indicator entered an Uptrend today. In 95 of 233 cases where IBN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 41%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 41%.
IBN broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: IBN's P/B Ratio (0.032) is slightly lower than the industry average of (1.262). P/E Ratio (0.216) is within average values for comparable stocks, (13.479). Projected Growth (PEG Ratio) (0.240) is also within normal values, averaging (1.190). Dividend Yield (0.027) settles around the average of (0.036) among similar stocks. P/S Ratio (4.323) is also within normal values, averaging (3.738).
The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. IBN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a regional bank
Industry RegionalBanks